Sleep and Circadian Rhythms in Mechanically Ventilated Patients
2 other identifiers
interventional
25
1 country
1
Brief Summary
This study examines the feasibility of assessing sleep and circadian rhythmicity in critically ill patients undergoing mechanical ventilation. Secondarily, it will examine the feasibility of reducing subject exposure to environmental light and noise and of delivering routine care according to classical day/night routines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2001
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 10, 2011
CompletedFirst Posted
Study publicly available on registry
January 13, 2011
CompletedResults Posted
Study results publicly available
September 26, 2017
CompletedSeptember 26, 2017
July 1, 2017
7.1 years
January 10, 2011
December 29, 2016
July 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Subjects Who Successfully Undergo Continuous Bedside Polysomnography for at Least 24 Hours.
This study assesses the feasibility of studying sleep and circadian rhythmicity in acutely ill, mechanically ventilated patients through the application of continuous bedside polysomnography. Feasibility will be assessed by determining the percentage of enrolled subjects who undergo at least 24 hours of continuous bedside polysomnography.
Average 4 days (patients followed to hospital discharge)
Secondary Outcomes (1)
Subject Tolerance of the Environmental Modification Protocol
Average 4 days (patients followed to hospital discharge)
Other Outcomes (2)
Occurrence of REM Sleep
Average 4 days (patients followed to hospital discharge)
Normal Timing of 6-sulfatoxymelatonin Excretion
Average 4 days (patients followed to hospital discharge)
Study Arms (3)
Environmental modification
ACTIVE COMPARATORSubjects assigned to this group receive the environmental modification intervention for 48 hours beginning the morning after enrollment.
Usual care (randomized)
NO INTERVENTIONUsual care is provided for the first 48 hours. Subsequently, in the initial protocol, subjects received 48 hours of the environmental modification intervention so long as they remained in the ICU during this time. The opportunity to receive the "Delayed" intervention was later removed from the protocol.
Usual care (observational)
NO INTERVENTIONUsual care was provided.
Interventions
Environmental modification consists of nursing-related efforts to optimize daytime light exposure, to minimize nighttime light and noise exposure, and to batch nursing care at night.
Eligibility Criteria
You may qualify if:
- Adults undergoing mechanical ventilation in the medical intensive care unit.
You may not qualify if:
- Central nervous system disease (stroke, seizure, dementia, etc)
- Metabolic or hypoxic encephalopathy
- Confirmed or suspected drug overdose
- Currently receiving neuromuscular blockers
- Coma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Iowalead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- The Brain Research Foundationcollaborator
- University of Chicagocollaborator
Study Sites (1)
University of Chicago
Chicago, Illinois, 60637, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Logistical issues related to the performance of continuous bedside polysomnography may vary from institution to institution, thereby limiting the generalizability of our results where the primary outcome measure is concerned.
Results Point of Contact
- Title
- Brian Gehlbach, MD
- Organization
- University of Iowa
Study Officials
- PRINCIPAL INVESTIGATOR
Brian K Gehlbach, MD
University of Chicago
- PRINCIPAL INVESTIGATOR
Jesse Hall, MD
University of Chicago
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor of Medicine
Study Record Dates
First Submitted
January 10, 2011
First Posted
January 13, 2011
Study Start
November 1, 2001
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
September 26, 2017
Results First Posted
September 26, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share
As this is a pilot study, there are no plans to share IPD.